Nutex Health Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the annual meeting of stockholders held on April 23, 2026. Nutex Health Inc. (NUTX), a Delaware corporation, is listed on The NASDAQ Stock Market LLC.
Key Financial Metrics
This filing is a current report regarding corporate governance matters and does not contain financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes and Voting Results
Of the 5,628,591 shares eligible to vote, 3,900,175 shares (approximately 69.29%) were voted. The following matters were approved:
- Director Elections: All seven nominees were elected for a one-year term expiring at the 2027 annual meeting. Frank E. Jaumot received the highest "For" vote count (2,623,902), while Warren Hosseinion received the lowest (2,512,649). Significant broker non-votes (1,256,968) were recorded for all director nominees.
- Executive Compensation: The advisory vote on named executive officer compensation was approved with 2,505,375 votes "For" and 126,612 votes "Against."
- Independent Auditor: Grant Thornton LLP was ratified as the independent registered public accounting firm for the year ending December 31, 2026, with 3,841,817 votes "For" and 25,441 votes "Against."
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risks, contingencies, or unusual items. The document is limited to the tabulation of shareholder votes.
Investor Verification Checklist
- Verify the total number of shares outstanding and eligible to vote as of the record date.
- Review the specific terms of the one-year director terms approved.
- Confirm the appointment of Grant Thornton LLP for the fiscal year ending December 31, 2026.
- Check subsequent filings for the full proxy statement to understand the context of the "Against" votes on executive compensation.